GEORGE BRYANT: Open Payments
NPI 1285625921 · RONCEVERTE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 28 payments from 8 companies in 2025. Trend: 2023 $424 · 2024 $378 · 2025 $478
Food & beverage: $446Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $202 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Amgen Inc. | 5 | $77 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| ABBVIE INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Philips North America LLC | 1 | $16 |
Products named: Ozempic, FARXIGA, REPATHA, Rybelsus, Wegovy, NEXLETOL, OTEZLA, NURTEC ODT.
Industry payments across WV — which companies pay providers there.
